At the United Nations General Assembly in September, President Trump highlighted his concerns about risky biological research. Significant questions remain, however, about how oversight of high-consequence research will be put into practice. Policymakers and researchers need a consistent and transparent way to weigh the risks and benefits of such research to facilitate review processes and oversight.

read more